维普期刊资源整合服务平台（V6.5）

108篇 您的检索式：作者名="Sherman Si"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer显示文摘	Kurzrock R Sherman SI Ball DW	2011	J Clin Oncol2011，29，19：	1
2	Thyroid carcinoma 显示文摘	Sherman SI	2003	Lancet2003，361，9356：	1
3	Motesanib diphosphate in progressive differentiated thyroid cancer 显示文摘	Sherman SI Wirth LJ Droz JP	2008	N Engl J Med2008，359，1：	1
4	Early clinical studies of novel therapies for thyroid cancers显示文摘	Sherman SI	2008	Endocrinol Metab Clin North Am2008，37，2：	1
5	Advances in chemotherapy of differentiated epithelial and medullary thyroid cancers显示文摘	Sherman SI	2009	J Clin Endocrinl Metab2009，94，5：	1
6	Thyroid carcinoma显示文摘	Sherman SI	2003	Lancet2003，361，9365：	1
7	Optimal treatment strategy in patients with papillary thyroid cancer: a decision analysis显示文摘	Esnaola NF Cantor SB Sherman SI	2001	Surgery2001，130，6：	1
8	Advances in chemotherapy of differentiated epithelial and medullary thyroid cancers 显示文摘	Sherman SI	2009	J Clin Endocrinol Metab2009，94，：	1
9	A phase II trial of the muhitargeted kinase inhibitor E7080 in advanced radioiodine ( RAI )-refractory differentiated thyroid cancer (DTC) 显示文摘	SHERMAN SI JARZAB B CABANILLAS ME	2011	J Clin Oncol2011，，：	1
10	Motesanib diphosphate in progressive differentiated thyroid cancer显示文摘	Sherman SI Wirth LJ Droz JP		0，，：	1
11	Motesanib diphosphate in progressive differentiated thyroid cancer显示文摘	Sherman SI Wirth LJ Droz JP	2008	N Engl J Med2008，359，1：	1
12	Thyroid carcinoma显示文摘	Sherman SI	2003	Lancet2003，361，：	1
13	Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phos- phatidylinositol 3 kihase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma 显示文摘	Santarpia L Myers JN Sherman SI	2010	Cancer2010，116，12：	1
14	Advances in chemotherapy of differentiated epithe- lial and medullary thyroid cancers 显示文摘	Sherman SI	2009	J Clin Endocrinol Metab2009，94，5：	1
15	Thyroid carcinoma显示文摘	Sherman SI	2003	Lancet2003，361，：	1
16	Approach to the patient with advanced differentiated thyroid cancer显示文摘	Schlumberger M Sherman SI	2012	Eur J Endocri-nol2012，166，1：	1
17	Thyroid carcinoma 显示文摘	Sherman SI	2003	Iancet2003，361，9356：	1
18	Rationale and design of decision:a double-blind,randomized,placebo-controlled phase Ⅲtrial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory,differentiated thyroid cancer显示文摘	Brose MS Nutting CM Sherman SI		0，，：	1
19	Thyroid carcinoma显示文摘	Sherman SI Angelos P Ball DW	2007	J Yatl Compr Canc Netw2007，5，6：	1
20	Approach to the patient with ad- vanced differentiated thyroid cancer显示文摘	Schlumberger M Sherman SI	2012	Eur J Endocrinol2012，166，1：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示